Booking ID : 13277155211
Sample Collection Date : 06/Apr/2025
KUSHAGRA BANGA
Male, 25 Yrs
A Comprehensive
Health Analysis Report
AI Based Personalized Report for You
INDIA’S FIRST & ONLY CREDIBILITY CHECK FOR YOUR LAB REPORT
Check the authenticity of your lab report with machine data
Scan the QR using any QR code scanner
Smart Report 3.0
HEALTH ANALYSIS KUSHAGRA BANGA
Personalized Summary & Vital Parameters Booking ID : 13277155211 | Sample Collection Date : 06/Apr/2025
KUSHAGRA BANGA,
Your Health Score
Congratulations, We have successfully completed your health diagnosis. This is a big
step towards staying on top of your health and identify potential to improve!
10 Vital Health Parameters of a Human Body Ecosystem
Below are the health parameters which require routine checkups for primary healthcare.
The view also includes personalised information depending on the tests you have taken.
75
Out of 100
*Calculated from test reports
Thyroid Function
Thyroid Stimulating Hormone Vitamin B12
(TSH)-Ultrasensitive : 2.85 Test not taken
µIU/ml
Everything looks good
Cholesterol Total
151.7 mg/dl Liver Function
Everything looks good Test not taken
Kidney Function Calcium Total
Test not taken Test not taken
Vitamin D Iron studies
Test not taken Test not taken
HbA1c Complete
4.8 % Hemogram
Everything looks good Test not taken
Patient Name : KUSHAGRA BANGA Barcode : E5284524
Age/Gender : 25Y 0M 0D /Male Sample Collected On : 06/Apr/2025 11:31AM
Order Id : 13277155211 Sample Received On : 06/Apr/2025 03:36PM
Referred By : Self Report Generated On : 06/Apr/2025 05:36PM
Customer Since : 06/Apr/2025 Sample Temperature : Maintained
Sample Type : Whole Blood EDTA ReportStatus : Final Report
DEPARTMENT OF BIOCHEMISTRY HBA1C
Test Name Value Unit Bio. Ref Interval
HbA1c - Glycosylated Hemoglobin
Hba1c (Glycosylated Hemoglobin) 4.80 % 4.2 - 5.7
Method: HPLC
Machine: BIORAD D100
Average Estimated Glucose - plasma 91.06 mg/dl
Method: Calculated
INTERPRETATION:
AS PER AMERICAN DIABETES ASSOCIATION (ADA):
REFERENCE GROUP GLYCOSYLATED HEMOGLOBIN (HBA1c) in %
Non diabetic <5.7
At Risk (Prediabetes) 5.7 – 6.4
Diagnosing Diabetes >= 6.5
Age > 19 Years
Goals of Therapy: < 7.0
Actions Suggested: >8.0
Therapeutic goals for glycemic control Age < 19 Years
Goal of therapy: <7.5
REMARKS
1. HbA1c is used for monitoring diabetic control. It reflects the mean plasma glucose over three months
2. HbA1c may be falsely low in diabetics with hemolytic disease. In these individuals a plasma fructosamine level may be used which evaluates diabetes over 15
days.
3. Inappropriately low HbA1c values may be reported due to hemolysis, recent blood transfusion, acute blood loss, hypertriglyceridemia, chronic liver disease. Drugs
like dapsone, ribavirin, antiretroviral drugs, trimethoprim, may also cause interference with estimation of HbA1c, causing falsely low values.
4. HbA1c may be increased in patients with polycythemia or post-splenectomy.
5. Inappropriately higher values of HbA1c may be caused due to iron deficiency, vitamin B12 deficiency, alcohol intake, uremia, hyperbilirubinemia and large doses of
aspirin.
6. Trends in HbA1c are a better indicator of diabetic control than a solitary test. 7. Any sample with >15% HbA1c should be suspected of having a hemoglobin
variant, especially in a non-diabetic patient. Similarly, below 4% should prompt additional studies to determine the possible presence of variant hemoglobin.
8. HbA1c target in pregnancy is to attain level <6 % .
9. HbA1c target in paediatric age group is to attain level < 7.5 %.
Method : Ion-exchange high-performance liquid chromatography (HPLC).
Reference : American Diabetes Associations. Standards of Medical Care in Diabetes 2023
10.The presence of some hemoglobinopathies/hemoglobin variants may be missed by some platforms used for measuring HbA1c values. In these cases, the HbA1c
result may vary or give deviant results, depending on the platform used. Alternative measures of glycemic control like fructosamine or glycated albumin may be
considered in such cases.
11.In presence of hemoglobinopathy/hemoglobin variants in homozygous/compound heterozygous conditions alternative forms of testing such as fructosamine or
glycated albumin may be considered.
Page 1 of 6
SIN No:E5284524
Patient Name : KUSHAGRA BANGA Barcode : E5284524
Age/Gender : 25Y 0M 0D /Male Sample Collected On : 06/Apr/2025 11:31AM
Order Id : 13277155211 Sample Received On : 06/Apr/2025 04:10PM
Referred By : Self Report Generated On : 06/Apr/2025 06:39PM
Customer Since : 06/Apr/2025 Sample Temperature : Maintained
Sample Type : Flouride Plasma ReportStatus : Final Report
DEPARTMENT OF BIOCHEMISTRY
Test Name Value Unit Bio. Ref Interval
Fasting Blood Sugar
Glucose, Fasting 83.1 mg/dl 70 - 100
Method: Hexokinase
Machine: BECKMAN COULTER DXC 700 AU
American Diabetes Association Reference Range :
Normal : < 100 mg/dl
Impaired fasting glucose(Prediabetes) : 100 - 125 mg/dl
Diabetes : >= 126 mg/dl
Conditions that can result in an elevated blood glucose level include:
Diabetes mellitus ,Hemochromatosis ,Cushing syndrome ,Acromegaly and gigantism.
Increased circulating epinephrine such as in pheochromocytoma and adrenalin injections
Acute pancreatitis
Chronic pancreatitis
Conditions that cause low blood glucose level include :
Pancreatic disorders : Islet cell tumor , pancreatitis
Hepatic disease (diffuse severe disease )
Endocrine disorders : hypopituitarism, Addison’s disease ,hypothyroidism
Alcoholism
Malnutrition
Page 2 of 6
SIN No:E5284524
Patient Name : KUSHAGRA BANGA Barcode : E5284524
Age/Gender : 25Y 0M 0D /Male Sample Collected On : 06/Apr/2025 11:31AM
Order Id : 13277155211 Sample Received On : 06/Apr/2025 03:23PM
Referred By : Self Report Generated On : 07/Apr/2025 02:49PM
Customer Since : 06/Apr/2025 Sample Temperature : Maintained
Sample Type : SERUM ReportStatus : Final Report
DEPARTMENT OF BIOCHEMISTRY
Test Name Value Unit Bio. Ref Interval
Lipid Profile Advance
Total Cholesterol 151.7 mg/dl Desirable : <200
Method: CHO-POD (Trac. Abel-Kendall) Borderline: 200-239
Machine: BECKMAN COULTER AU 5800
High : >/=240
Serum Triglycerides 143.6 mg/dl Desirable : <150
Method: GPO-POD Borderline high : 150-199
Machine: BECKMAN COULTER AU 5800
High : 200-499
Very high : >= 500
Serum HDL Cholesterol 28.8 mg/dl 40 - 60
Method: ENZYMATIC IMMUNOINHIBITION
Machine: BECKMAN COULTER AU 5800
Serum LDL Cholesterol 104.5 mg/dl Optimal : <100
Method: ENZYMATIC SELECTIVE PROTECTION near /above Optimal:100 -
Machine: BECKMAN COULTER AU 5800
129
Borderline High:130 - 159
High : 160 - 189
Very High :>/=190
Serum VLDL Cholesterol 18.4 mg/dl <30
Method: Calculated
Machine: BECKMAN COULTER AU 5800
Total CHOL / HDL Cholesterol Ratio 5.27 Ratio 3.30 - 4.40
Method: Calculated
LDL / HDL Cholesterol Ratio 3.63 Ratio Desirable/Low Risk: 0.5-3.0
Method: Calculated Line/Moderate Risk: 3.0-6.0
Elevated/High Risk: >6.0
HDL / LDL Cholesterol Ratio 0.28 Ratio Optimal->0.4
Method: Calculated Moderate-0.4 to 0.3
High-<0.3
Non-HDL Cholesterol 122.9 mg/dl 0.0 - 160.0
Method: Calculated
Dyslipidemia is a disorder of fat or lipoprotein metabolism in the body and includes lipoprotein overproduction or deficiency.
Dyslipidemias means increase in the level of one or more of the following: Total Cholesterol, low density lipoprotein (LDL) and/or triglyceride
concentrations.
Dyslipidemia also includes a decrease in the “good" cholesterol or high-density lipoprotein (HDL) concentration in the blood.
Page 3 of 6
SIN No:E5284524
Patient Name : KUSHAGRA BANGA Barcode : E5284524
Age/Gender : 25Y 0M 0D /Male Sample Collected On : 06/Apr/2025 11:31AM
Order Id : 13277155211 Sample Received On : 06/Apr/2025 03:23PM
Referred By : Self Report Generated On : 07/Apr/2025 02:49PM
Customer Since : 06/Apr/2025 Sample Temperature : Maintained
Sample Type : SERUM ReportStatus : Final Report
DEPARTMENT OF BIOCHEMISTRY
Test Name Value Unit Bio. Ref Interval
Cholesterol is a steroid carried in the bloodstream as lipoprotein, necessary for cell membrane functioning and as a precursor to bile acids,
progesterone ,vitamin D ,estrogens ,glucocorticoids and mineralocorticoids.
HDL is termed “good cholesterol” because its levels are inversely related to the risk of Coronary heart disease.
LDL cholesterol is termed the “bad cholesterol” and their increased levels are associated with increased risk of atherosclerosis and coronary
heart disease.
Lipid level assessments must be made following 9 to 12 hours of fasting, otherwise assay results might lead to erroneous interpretation.
Healthians labs report biological reference intervals (normal ranges) in accordance with the recommendations of The National Cholesterol
Education Program (NCEP) & Adult Treatment Panel IV (ATP IV) guidelines providing the most desirable targets of various circulating lipid
fractions in the blood. NCEP recommends that all adults above 20 years of age must be screened for abnormal lipid levels.
Page 4 of 6
SIN No:E5284524
Patient Name : KUSHAGRA BANGA Barcode : E5284524
Age/Gender : 25Y 0M 0D /Male Sample Collected On : 06/Apr/2025 11:31AM
Order Id : 13277155211 Sample Received On : 06/Apr/2025 03:01PM
Referred By : Self Report Generated On : 06/Apr/2025 09:02PM
Customer Since : 06/Apr/2025 Sample Temperature : Maintained
Sample Type : Serum ReportStatus : Final Report
DEPARTMENT OF IMMUNOLOGY
Test Name Value Unit Bio. Ref Interval
INSULIN (FASTING)
INSULIN (FASTING) 9.01 µIU/mL 1.9 - 23
Method: CLIA
Machine: Beckman Coulter UniCel DxI800
Test Interpretation:-
Insulin is produced in the secretory granules of the beta cells of the pancreas. Secretion is regulated primarily by blood glucose levels; therefore, it should always
be measured with concomitant blood glucose. Insulin deficiency is a crucial factor in the pathogenesis of type 1 Diabetes Mellitus.
Uses:
• To diagnose the presence of an insulin-producing tumor in the islet cells of the pancreas (insulinoma);
• to help determine the cause of low blood glucose (hypoglycemia);
• to help identify insulin resistance,
• to help determine when a type 2 diabetic might need to start taking insulin to supplement oral medications.
Interpretation:
Increased in:
• Insulinoma. Fasting blood insulin level >50 μU/mL in the presence of low or normal blood glucose level. Administration of tolbutamide or leucine causes a rapid rise
of blood insulin to very high levels within a few minutes, with a rapid return to normal.
• Factitious hypoglycemia in the presence of normal blood glucose.
• Insulin autoimmune syndrome.
• Untreated mild DM in obese individuals. The fasting blood level is often increased.
• Cirrhosis due to insufficient clearance from blood.
• Acromegaly (especially with active disease) after ingestion of glucose.
• Reactive hypoglycemia after glucose ingestion, particularly with the diabetic type of glucose tolerance curve.
Decreased in:
• Type 1 Diabetes mellitus (DM)
• Hypopituitarism.
• Severe DM with ketosis and weight loss, which may result in an absence of insulin.
Page 5 of 6
SIN No:E5284524
Patient Name : KUSHAGRA BANGA Barcode : E5284524
Age/Gender : 25Y 0M 0D /Male Sample Collected On : 06/Apr/2025 11:31AM
Order Id : 13277155211 Sample Received On : 06/Apr/2025 03:23PM
Referred By : Self Report Generated On : 07/Apr/2025 06:40PM
Customer Since : 06/Apr/2025 Sample Temperature : Maintained
Sample Type : Serum ReportStatus : Final Report
DEPARTMENT OF IMMUNOLOGY
Test Name Value Unit Bio. Ref Interval
Thyroid Profile (Total T3,T4, TSH)
Tri-Iodothyronine (T3, Total) 1.12 ng/mL 0.87-1.78
Method: CLIA
Machine: Beckman Coulter UniCel DxI800
Thyroxine (T4, Total) 12.08 µg/dL 5.48-14.28
Method: CLIA
Machine: Beckman Coulter UniCel DxI800
Thyroid Stimulating Hormone (TSH)-Ultrasensitive 2.848 µIU/ml 0.38-5.33
Method: CLIA
Machine: Beckman Coulter UniCel DxI800
Pregnancy interval Bio Ref Range for TSH in uIU/ml (As per American Thyroid Association)
First trimester 0.1 - 2.5
Second trimester 0.2 – 3.0
Third trimester 0.3 – 3.0 Healthians
recommends that the following potential sources of variation should be considered while interpreting thyroid hormone results:
1. Thyroid hormones undergo rhythmic variation within the body this is called circadian variation in TSH secretion: Peak levels are seen between
2-4 AM. Minimum levels seen between 6-10 AM. This variation may be as much as 50% thus, influence of sampling time needs to be considered
for clinical interpretation.
2. Circulating forms of T3 and T4 are mostly reversibly bound with Thyroxine binding globulins (TBG), and to a lesser extent with albumin and
Thyroid binding Pre-Albumin. Thus the conditions in which TBG and protein levels alter such as chronic liver disorders, pregnancy, excess of
estrogens, androgens, anabolic steroids and glucocorticoids may cause misleading total T3, total T4 and TSH interpretations.
3. Total T3 and T4 levels are seen to have physiological rise during pregnancy and in patients on steroid treatment.
4. T4 may be normal even in the presence of hyperthyroidism under the following conditions : T3 thyrotoxicosis, Hypoproteinemia related reduced
binding, during intake of certain drugs (eg Phenytoin, Salicylates etc)
5. Neonates and infants have higher levels of T4 due to increased concentration of TBG
6. TSH levels may be normal in central hypothyroidism, recent rapid correction of hypothyroidism or hyperthyroidism, pregnancy, phenytoin therapy
etc.
7. TSH values of <0.03 uIU/mL must be clinically correlated to evaluate the presence of a rare TSH variant in certain individuals which is
undetectable by conventional methods.
8. Presence of Autoimmune disorders may lead to spurious results of thyroid hormones.
9. Various drugs influence the levels of thyroid hormones such as L-Dopa, Lithium, Glucocorticoids, Phenytoin etc.
10. Healthians recommends evaluation of unbound fractions, that is free T3 (fT3) and free T4 (fT4) for clinic-pathologic correlation, as these are
the metabolically active forms.
*** End Of Report ***
Page 6 of 6
SIN No:E5284524
Smart Report 3.0
ADVISORY KUSHAGRA BANGA
Health Advisory Booking ID : 13277155211 | Sample Collection Date : 06/Apr/2025
No Data Body Mass Index 6'0" Height (ft/in) No Data Weight (kgs.)
Physical Activity Smoke Food Preference Alcohol Medication Family History
No Data No Data No Data No Data No Data No Data
Blood Pressure Pulse Rate Waist (In Cm) Hip Circumference (In Cm) SPO2 Levels Sugar Levels
No Data No Data No Data No Data No Data No Data
Additional Remarks :
NA
EVERYTHING LOOKS GOOD!
As per your test results, We would recommend you to continue taking a balanced diet
and reach out to our team for any queries.
EVERYTHING LOOKS GOOD!
As per your test results, We would recommend you to continue a healthy lifestyle
and reach out to our team for any queries.
EVERYTHING LOOKS GOOD!
As per your test results, We would recommend you to regularly take preventive
health checkups for well-being.
